Security key
68236X100
Starling Oncology, Inc. - Common Stock, par value $0.0001 per share (TOI)
CUSIP: 68236X100
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 31,474,503
- Total 13F value
- $64,523,702
- Share change
- +14,567,548
- SEC-reported price per share
- $2.05
- Number of holders
- 78
- Value change
- +$31,211,552
- Number of buys
- 64
- Number of sells
- 10
- Shares outstanding
- 101,268,340
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
78
Top holders
10
TOI full security history
Ownership snapshot
Full 13F holder table
Oncology Institute, Inc. SEC filings
Oncology Institute, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TOI - Starling Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ravi Yang Sarin
Disclosed value leader
Ravi Yang Sarin
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
3/4/5
13F
Lead comparable stake: 4.7%
13D/G row: Ravi Yang Sarin
Showing 1-6 of 15 holder rows.
Quick read
Ravi Yang Sarin leads the comparable SEC ownership view at 4.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ravi Yang Sarin's linked filing trail.
Comparable ownership
Top 5
Ravi Yang Sarin
4.7%
DEERFIELD MANAGEMENT COMPANY, L.P.
3.3%
TIFF ADVISORY SERVICES, LLC
2.9%
BALYASNY ASSET MANAGEMENT L.P.
2.1%
JOSH ARNOLD INVESTMENT CONSULTANT...
2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ravi Yang Sarin |
13D/G
3/4/5
Ravi Sarin · Director
|
4.7%
|
$11,959,434
4,109,771 shares
|
$0 | 26 Mar 2025 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
3.3%
|
$3,830,459
3,360,052 shares
|
— | 31 Mar 2025 |
| TIFF ADVISORY SERVICES, LLC |
13F
Company
|
2.9%
|
$3,396,221
2,979,141 shares
|
— | 31 Mar 2025 |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
2.1%
|
$2,447,958
2,147,332 shares
|
— | 31 Mar 2025 |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC |
13F
Company
|
2%
|
$2,267,346
1,988,900 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1.7%
|
$1,995,814
1,750,714 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
31,474,503
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
42
Q2 2025 holders
78
Holder diff
36
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|